The Smoking Cessation Center has multiple, ongoing research studies primarily investigating new medications for treatment of tobacco dependence.
- Pfizer - A Phase 4 Randomized Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Neuropsychiatric Safety and Efficacy of 12 Weeks Varenicline Tartrate 1MG BID and Bupropion Hydrochloride 150 MB BID for Smoking Cessation in Subjects With and Without a History of Psychiatric Disorders:
David Gonzales, PhD, Principal Investigator
- Analysis of predictors of smoking abstinence after discharge from the OHSU hospital.
Wendy Bjornson, MPH Principal Investigator
Past Research Studies
View our Past Research Studies Archive
Smoking Cessation Center Research Publications
The faculty of the Smoking Cessation Center at OHSU have published many articles on smoking cessation and related topics.